My Application Form Status

Check the status of your application form with Angel Broking.
Arq - The Hyper Intelligent Investment Engine By Angel Broking

Visaka Industries Ltd Research Report - 21st May 2016

Miscellaneous | Published on May 21st 2016


Visaka Industries posted a good set of numbers for 4QFY2016. Although the top-line declined, the performance on the operating and bottom-line fronts was favorable. The top-line declined by 3.3% yoy to Rs276cr. On the operating front the EBITDA grew by 6.6% yoy to Rs29cr and the EBITDA margin improved by 96bp yoy to 10.4%. There was an exceptional expense related to diminution in value of investment during the quarter amounting to Rs1cr, adjusting for which, other expenses declined by 192bp yoy to 24.6% of sales. Raw material and employee expenses remained flat as a proportion of sales, thus resulting in EBITDA margin expansion. Aided by lower interest and depreciation, the adjusted net profit grew by 58.6% yoy to Rs10cr. Overall long term prospects intact: The company’s performance in FY2016 was impacted on account of drop in volumes and realizations for its main business, ie Asbestos Cement Sheets (ACS). However, the company is aiming at growing its Boards and Synthethic yarn business in order to lower its dependence on the ACS business. While the long term prospects of ACS are intact the outlook for the Boards and Synthetic yarn business also looks favorable which should drive growth for the company going forward. The Yarn business has better margins while the Boards business has shown significant improvement in profitability which should only improve once the business scales up. Outlook and Valuations: We have introduced our FY2018E estimates for the company and have lowered our expectation for FY2017E on account of near term dampness in the ACS division. At the current market price of Rs135, the stock is trading at a valuation of 5.9x its FY2018E EPS, which is attractive. We continue to maintain our Buy rating on the stock with a revised price target of Rs162, valuing the stock at 7.0x its FY2018E earnings.

Download Full Report


CMP 135
Target Price 162
Investment Period12 Months

Stock Info

MCAP BSE (Rs in Cr)Array
MCAP NSE (Rs in Cr)Array
P/E (x)Array
EPS (Rs.)Array
BV (Rs.)Array
Div Yield (%)Array
FV (Rs.)Array
P/BV (x)Array
EV/Sales (x)Array
EV/EBITDA (x)Array

Shareholding Pattern (%)

Public & Others55.0
Grand Total100.0

Trade Securely


Portfolio Tracking & Trading Application View Demo